| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/05/1993 | CA2128536A1 Azabicyclo compounds as calcium channel antagonists |
| 08/05/1993 | CA2125877A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
| 08/05/1993 | CA2107348A1 N-sulfonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors |
| 08/04/1993 | EP0554107A1 Substituted triazoles as angiotensin II inhibitors |
| 08/04/1993 | EP0553682A1 Imidazo 4,5-b pyridine derivatives as Angiotensin II antagonists |
| 08/04/1993 | CN1074906A New 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their preparation and their use in medicaments |
| 08/04/1993 | CN1021734C Process for preparing pyrimido |5, 4-b¨ |1, 4¨ oxazine derivs. |
| 08/03/1993 | US5232941 Caffeic acid derivatives and pharmaceutical compositions containing the same |
| 08/03/1993 | US5232930 2-heteroaryl-substituted benzodioxoic having 5-lipoxygenase inhibitory activity |
| 08/03/1993 | US5232929 Treatment and prevention of inflammatory and central nervous system disorders |
| 08/03/1993 | US5232922 Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates |
| 08/03/1993 | US5232920 N-(mercaptoalkyl)amides |
| 08/03/1993 | CA1320958C 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them |
| 08/03/1993 | CA1320957C Pyridazinone derivatives |
| 08/03/1993 | CA1320954C .alpha.-adrenergic receptor antagonists |
| 08/03/1993 | CA1320953C .alpha.-adrenergic receptor antagonists |
| 08/03/1993 | CA1320904C Method for the treatment of atherosclerosis, thrombosis and peripheral vessel disease |
| 08/03/1993 | CA1320885C Controlled porosity osmotic pump |
| 08/01/1993 | CA2088464A1 A new pyridine bicyclic derivatives, process for preparing the same, new intermediates obtained, apllication of the same as drugs, and pharmac eutical compositions containing thesame |
| 07/31/1993 | CA2088347A1 Substituted triazoles as angiotensin ii inhibitors |
| 07/31/1993 | CA2088209A1 4-cinnolinyl- and 4-naphthyridinyl-dihydropyridines, processes for their preparation and their use in medicaments |
| 07/31/1993 | CA2087504A1 Administration of low dose hemoglobin to increase perfusion |
| 07/29/1993 | DE4201554A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs. |
| 07/29/1993 | CA2088220A1 Heterocyclic derivatives |
| 07/28/1993 | EP0553016A1 New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them |
| 07/28/1993 | EP0552765A1 Benzimidazoles, pharmaceutical compositions containing them and process for their preparation |
| 07/28/1993 | EP0552379A1 Dihydropyridine derivatives, and process for their preparation. |
| 07/28/1993 | EP0552329A1 Methylen-oxindole derivatives and process for their preparation |
| 07/28/1993 | EP0552246A1 Therapeutically useful 2-aminotetralin derivatives |
| 07/28/1993 | EP0552238A1 Cyclopeptides, a method of preparing them, and their use as drugs |
| 07/28/1993 | EP0552227A1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation. |
| 07/27/1993 | US5231103 Quinolin-2-yl-methoxybenzylhydroxyureas |
| 07/27/1993 | US5231096 Anesthetic for central nervous system |
| 07/27/1993 | US5231090 Treatment for hypercholesterolemia |
| 07/27/1993 | US5231083 Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia |
| 07/27/1993 | CA1320748C Inclination measuring device and a capsule therefor |
| 07/27/1993 | CA1320726C Sulphonamide antiarrhythmic agents |
| 07/24/1993 | WO1993015081A1 Morphinan derivative and medicinal use |
| 07/23/1993 | CA2087800A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/23/1993 | CA2087772A1 Naphthalenic amides and sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
| 07/22/1993 | WO1993014124A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | WO1993014121A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014120A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014119A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | WO1993014115A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/22/1993 | WO1993014112A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
| 07/22/1993 | WO1993014102A1 New adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 07/22/1993 | WO1993014082A1 Pyridyl substituted imidazoles |
| 07/22/1993 | WO1993014081A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | WO1993014077A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| 07/22/1993 | WO1993014076A1 Piperazine derivatives as 5-ht receptors antagonists |
| 07/22/1993 | WO1993014072A1 Amino acid derivatives as paf-receptor antagonists |
| 07/22/1993 | WO1993014067A1 Nitroquinolone derivatives as nmda antagonists |
| 07/22/1993 | WO1993013773A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
| 07/22/1993 | WO1993013771A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 07/22/1993 | WO1993013769A1 Pyropheophorbides and their use in photodynamic therapy |
| 07/22/1993 | WO1993013762A1 Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 07/22/1993 | WO1993013741A2 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 07/22/1993 | WO1993013660A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 07/22/1993 | WO1993010742A3 Chemical compounds, their preparation and use |
| 07/22/1993 | WO1993006852A3 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/22/1993 | WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 07/22/1993 | CA2368862A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2351694A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2314425A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2127540A1 Tie, a novel endothelial cell receptor tyrosine kinase |
| 07/22/1993 | CA2127365A1 Amino acid derivatives as paf-receptor antagonists |
| 07/22/1993 | CA2127250A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2127249A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2127248A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | CA2126864A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
| 07/22/1993 | CA2126687A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
| 07/22/1993 | CA2126076A1 Nitroquinolone derivatives as nmda antagonists |
| 07/22/1993 | CA2125182A1 Piperazine derivatives as 5-ht receptors antagonists |
| 07/22/1993 | CA2123576A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/21/1993 | EP0551927A1 Method for the treatment of cardiac insufficiency |
| 07/21/1993 | EP0551729A1 Gamma-linolenic acid for the preparation of a medicament for preventing reocclusion of arteries |
| 07/21/1993 | EP0551663A1 Dimethyl 2,6-dimethyl-1n-propyl-4-(4-trifluormethylphenyl)-1,4-dihydro-pyridine-3,5-dicarboxylate, method for its production and its pharmaceutical use |
| 07/21/1993 | EP0551427A1 Beta-carotene and vitamin e therapy for inhibition of major vascular events |
| 07/20/1993 | US5229505 CNS and cardiovascular effects |
| 07/20/1993 | US5229410 Antidepressant, tranquilizers |
| 07/20/1993 | US5229409 6-substituted-tetrahydrobenz[cd]indoles |
| 07/20/1993 | US5229399 Analgesics |
| 07/20/1993 | US5229373 Reduction of neurotoxic effects caused by chemotherapy |
| 07/20/1993 | CA1320493C Substituted thieno (2,3-.beta.) thiophene-2-sulfonamides as antiglauc oma agents |
| 07/20/1993 | CA1320492C Process for the preparation of novel 2-thienyl-oxyacetic acid derivatives |
| 07/20/1993 | CA1320485C .alpha. -adrenergic receptor antagonists |
| 07/15/1993 | CA2087245A1 Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use |
| 07/14/1993 | EP0557290A4 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss. |
| 07/14/1993 | EP0551219A1 Pyridylsulfonylurea, processes for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0551182A1 Method of treating hyperproliferative vascular disease using rapamycin, eventually in combination with mycophenolic acid |
| 07/14/1993 | EP0550737A1 Controlled release verapamil tablet. |
| 07/14/1993 | EP0550703A1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs |
| 07/14/1993 | EP0550697A1 Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same |
| 07/14/1993 | EP0550576A1 Phenylpyridinol derivatives as medicaments |
| 07/14/1993 | EP0550568A1 Anti-atherosclerotic aryl compounds |
| 07/14/1993 | EP0550502A1 Substituted imidazoles, their preparation and pharmaceutical compositions |
| 07/14/1993 | EP0550478A1 Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions |
| 07/14/1993 | EP0550464A1 Antiviral compounds and antihypertensive compounds |
| 07/13/1993 | US5227518 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis |